ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 598

Identification of Potential Risk Factors for Spinal Structural Damage in Chinese Patients with Ankylosing Spondylitis

Weiping Kong1, Caroline Jefferies 2, Tom Learch 2, Feng Zhu 1, Nan Zhang 1, Dier Jin 1, Yingze Zhang 1, Qingwen Tao 1, Xiaoping Yan 1, Michael Weisman 3 and Mariko Ishimori 2, 1China-Japan Friendship Hospital, Beijing, China (People's Republic), 2Cedars-Sinai Medical Center, Los Angeles, CA, 3David Geffen School of Medicine at UCLA, Los Angeles, CA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Ankylosing spondylitis (AS), modified stoke ankylosing spondylitis spinal score (MSASSS) and risk assessment

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Spinal structural damage can lead to physical dysfunction and decline of spinal mobility in patients with ankylosing spondylitis (AS). Although great progress has been made to identify potential risk factors associated with the severity of spinal structural damage, there is no definite consensus on how many factors are actually involved in its development. To yield more information, we conducted a cross-sectional study in 270 Chinese AS patients, aiming to identify potential risk factors responsible for the severity of spinal structural damage, both individually and in combination.

Methods: In total, 270 AS patients fulfilled the modified New York criteria. Computed tomography (CT) scans and lumbar/cervical X-rays were used to separately assess BASRI-SI, BASRI-hips and modified Stoke Ankylosing Spondylitis Spine Score (mSASSS), which were scored by a trained rheumatologist and a musculoskeletal radiologist where the inter-rater reliability (average kappa: 87.3%) was excellent. Spinal structural damage was appraised by mSASSS that was binarized at a cutoff of 10. Hip involvement was defined as BASRI-hips >0. Univariate and multivariate logistic regression analyses were done to identify potential risk factors for the severity of spinal structural damage, and nomogram graph was presented to facilitate clinical assessment. Statistical analyses were completed using the STATA software (v14.1) and R language (v3.5.1).

Results: 183 AS patients had mSASSS < 10 (low mSASSS), and 87 patients had mSASSS ≥10 (high mSASSS) (Table 1). Univariate analysis revealed that AS onset age, body mass index (BMI), duration of smoking, duration of symptoms, diagnosis delay, hip involvement and sacroiliitis grade were significantly associated with the risk of having high mSASSS, and all remained significant after adjusting for age, gender and HLA-B27 (all p< 0.05) (Table 2). In further analyses, hip involvement was found to be in significant interaction with BMI and duration of smoking in a graded manner. For instance, relative to patients with low BMI and negative hip involvement, those with high BMI and negative hip involvement, low BMI and positive hip involvement, and high BMI and positive hip involvement had a 1.94-, 3.29- and 5.07-fold increased risk of having high mSASSS (95% confidence interval: 0.84-4.47, 1.37-7.89, and 1.97-13.06, p=0.118, 0.008 and 0.001), respectively. To facilitate clinical assessment, a nomogram graph (Figure 1) based on 7 significant risk factors was generated with decent prediction accuracy (C-index: 0.906 and p< 0.001), and importantly besides sacroiliitis grade, onset age and BMI carried a greater weight than other risk factors.

Conclusion: We have identified seven potential risk factors responsible for the severity of spinal structural damage in Chinese AS patients. Importantly, positive hip involvement, in combination with high BMI or long duration of smoking, was associated with a remarkably increased risk of having severe structural damage in spine. Hip involvement was prevalent in our cohort and use of CT may have increased identification of hip findings compared to past studies in which X-rays were reviewed.

Table 1. Baseline characteristics of study patients with ankylosing spondylitis

Table 2. Identification of significant risk factors for spinal structural damage

Figure 1. Nomogram graph for the risk prediction of spinal structural damage using significant risk factors


Disclosure: W. Kong, None; C. Jefferies, None; T. Learch, None; F. Zhu, None; N. Zhang, None; D. Jin, None; Y. Zhang, None; Q. Tao, None; X. Yan, None; M. Weisman, AbbVie, 9, Boehringer Ingelheim, 9, Eli Lilly, 5, Lilly, 5, 9, Novartis, 5, Paul Hastings, 9, SetPoint Medical, 9, Takeda, 9, Tharpe & Howell LLP, 9, UCB, 5; M. Ishimori, None.

To cite this abstract in AMA style:

Kong W, Jefferies C, Learch T, Zhu F, Zhang N, Jin D, Zhang Y, Tao Q, Yan X, Weisman M, Ishimori M. Identification of Potential Risk Factors for Spinal Structural Damage in Chinese Patients with Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/identification-of-potential-risk-factors-for-spinal-structural-damage-in-chinese-patients-with-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-potential-risk-factors-for-spinal-structural-damage-in-chinese-patients-with-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology